DexCom, Inc.

NasdaqGS:DXCM Stock Report

Market Cap: US$23.5b

DexCom Dividends and Buybacks

Dividend criteria checks 0/6

DexCom does not have a record of paying a dividend.

Key information

n/a

Dividend yield

0.7%

Buyback Yield

Total Shareholder Yield0.7%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

Recent updates

Earnings Beat: DexCom, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Nov 02
Earnings Beat: DexCom, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

DexCom May Be The Most Underrated Growth Story In Healthcare

Oct 06

We Think DexCom (NASDAQ:DXCM) Can Manage Its Debt With Ease

Jul 22
We Think DexCom (NASDAQ:DXCM) Can Manage Its Debt With Ease

DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading Higher

Jul 09
DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading Higher

Is DexCom, Inc. (NASDAQ:DXCM) Trading At A 24% Discount?

May 16
Is DexCom, Inc. (NASDAQ:DXCM) Trading At A 24% Discount?

Why We're Not Concerned Yet About DexCom, Inc.'s (NASDAQ:DXCM) 25% Share Price Plunge

Apr 04
Why We're Not Concerned Yet About DexCom, Inc.'s (NASDAQ:DXCM) 25% Share Price Plunge

What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing?

Mar 06
What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing?

DexCom: Valuation Does Not Factor In Slowing Growth

Mar 04

Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts

Feb 21
Earnings Miss: DexCom, Inc. Missed EPS By 7.8% And Analysts Are Revising Their Forecasts

DexCom, Inc.'s (NASDAQ:DXCM) Intrinsic Value Is Potentially 38% Above Its Share Price

Feb 14
DexCom, Inc.'s (NASDAQ:DXCM) Intrinsic Value Is Potentially 38% Above Its Share Price

DexCom: Fairly Priced In 2025; Why I'm Not Expecting A Share Price Comeback

Jan 17

DexCom: Brighter 2025 From Stelo Ramp

Dec 10

Is It Too Late To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?

Dec 05
Is It Too Late To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?

DexCom Growing Into Its Valuation, But Still No Bargain

Oct 25

DexCom Q3 Preview: Walking On Eggshells With Its Channel Relationships

Oct 16

DexCom: Investors Discounting Long CGM Growth Runway

Sep 19

DexCom Q2 Earnings: Traditional Market Overreaction

Aug 07

DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures

Jul 26

DexCom's ADA Conference Takeaways: Stelo, CGM Tailwinds Still Intact

Jul 03

Dexcom: Positive Catalysts Ahead To Support Growth

May 13

DexCom: Attractive Discount After Strong Earnings Results

May 06

DexCom Is Pricey For A Reason - Its Growth Story Reflects That

Apr 11

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if DXCM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DXCM's dividend payments have been increasing.

Dividend Yield vs Market

DexCom Dividend Yield vs Market
How does DXCM dividend yield compare to the market?
SegmentDividend Yield
Company (DXCM)n/a
Market Bottom 25% (US)1.5%
Market Top 25% (US)4.6%
Industry Average (Medical Equipment)1.7%
Analyst forecast (DXCM) (up to 3 years)0%

Notable Dividend: Unable to evaluate DXCM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DXCM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate DXCM's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as DXCM has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/19 22:34
End of Day Share Price 2025/11/18 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DexCom, Inc. is covered by 53 analysts. 26 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Travis SteedBarclays
Matthew MiksicBarclays